WallStreetZenWallStreetZen

NASDAQ: BRTX
Biorestorative Therapies Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Biorestorative Therapies earnings were -$11.1M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest BRTX earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$2.2M, down 32.8% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, BRTX reported annual earnings of -$14.2M, with 58.6% growth.

BRTX earnings history

Current Revenue
$357.9k
Current Earnings
-$11.1M
Current Profit Margin
-3,089.6%

BRTX Return on Equity

Current Company
-423.8%
Current Industry
-141.9%
Current Market
13.5%
BRTX's Return on Equity (-423.8%)... subscribe to Premium to read more.
High Return on Equity Performance

BRTX Return on Assets

Current Company
-193.3%
Current Industry
-13.7%
BRTX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when BRTX announces earnings.

BRTX Return on Capital Employed

Current Company
-365.43%
Current Industry
-9.5%
BRTX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BRTX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
BRTX-$10.85M-$11.06MN/A-$1.07
INTS-$10.67M-$10.69MN/A-$6.07
KPRX-$12.21M-$11.06MN/A-$2.67
BCDA-$7.26M-$7.78MN/A-$0.91
APRE-$12.52M-$11.95MN/A-$1.50
View Top Biotech Stocks

Biorestorative Therapies Earnings Reports & History FAQ

What were Biorestorative Therapies's earnings last quarter?

On BRTX's earnings call on Invalid Date, Biorestorative Therapies (NASDAQ: BRTX) reported Q1 2026 earnings per share (EPS) of -$0.12, up 81.25% year over year. Total BRTX earnings for the quarter were -$2.15 million. In the same quarter last year, Biorestorative Therapies's earnings per share (EPS) was -$0.64.

If you're new to stock investing, here's how to buy Biorestorative Therapies stock.

Is Biorestorative Therapies profitable or losing money?

As of the last Biorestorative Therapies earnings report, Biorestorative Therapies is currently losing money. Biorestorative Therapies's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$11.06 million, a 8.59% decrease year over year.

What was BRTX's earnings growth in the past year?

As of Biorestorative Therapies's earnings date in Invalid Date, Biorestorative Therapies's earnings has grown year over year. BRTX earnings in the past year totalled -$11.06 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.